
Sihong Huang
Examiner (ID: 14444)
| Most Active Art Unit | 2736 |
| Art Unit(s) | 2632, 2617, 2736 |
| Total Applications | 250 |
| Issued Applications | 200 |
| Pending Applications | 18 |
| Abandoned Applications | 32 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18675611
[patent_doc_number] => 20230313229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => Genetic Construct
[patent_app_type] => utility
[patent_app_number] => 18/043276
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043276 | Genetic Construct | Aug 24, 2021 | Pending |
Array
(
[id] => 18658059
[patent_doc_number] => 20230304038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME
[patent_app_type] => utility
[patent_app_number] => 18/022059
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022059
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022059 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME | Aug 18, 2021 | Pending |
Array
(
[id] => 18675609
[patent_doc_number] => 20230313227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA
[patent_app_type] => utility
[patent_app_number] => 18/021364
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -166
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021364
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021364 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA | Aug 12, 2021 | Abandoned |
Array
(
[id] => 18485186
[patent_doc_number] => 20230212513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 18/009192
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009192 | COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION | Jun 16, 2021 | Pending |
Array
(
[id] => 18709557
[patent_doc_number] => 20230332177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => CORONAVIRUS PSEUDOVIRUS PACKAGING SYSTEM, PACKAGING METHOD THEREFOR, AND APPLICATION OF CORONAVIRUS PSEUDOVIRUS IN EVALUATING DISINFECTION EFFICACY
[patent_app_type] => utility
[patent_app_number] => 18/010885
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010885
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010885 | Coronavirus pseudovirus packaging system, packaging method therefor, and application of coronavirus pseudovirus in evaluating disinfection efficacy | Jun 14, 2021 | Issued |
Array
(
[id] => 18511676
[patent_doc_number] => 20230227858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => CELL LINES WITH MULTIPLE DOCKS FOR GENE INSERTION
[patent_app_type] => utility
[patent_app_number] => 18/007602
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007602
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007602 | CELL LINES WITH MULTIPLE DOCKS FOR GENE INSERTION | Jun 1, 2021 | Pending |
Array
(
[id] => 17297025
[patent_doc_number] => 20210392864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)
[patent_app_type] => utility
[patent_app_number] => 17/335568
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335568 | Genetically modified rat models for severe combined immunodeficiency (SCID) | May 31, 2021 | Issued |
Array
(
[id] => 18920524
[patent_doc_number] => 20240023528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => ONE-LOCUS INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE OR TEMPERATURE-INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE
[patent_app_type] => utility
[patent_app_number] => 17/926970
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926970 | ONE-LOCUS INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE OR TEMPERATURE-INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE | May 24, 2021 | Pending |
Array
(
[id] => 18467091
[patent_doc_number] => 20230201372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SLC26A4-ASSOCIATED HEARING LOSS
[patent_app_type] => utility
[patent_app_number] => 17/924933
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924933
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924933 | COMPOSITIONS AND METHODS FOR TREATING SLC26A4-ASSOCIATED HEARING LOSS | May 11, 2021 | Pending |
Array
(
[id] => 18391734
[patent_doc_number] => 20230159952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN NEOCORTICAL LAYER 5 GLUTAMATERGIC NEURONS
[patent_app_type] => utility
[patent_app_number] => 17/996910
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996910 | ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN NEOCORTICAL LAYER 5 GLUTAMATERGIC NEURONS | Apr 20, 2021 | Pending |
Array
(
[id] => 18649841
[patent_doc_number] => 20230295666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SUPER-ENCHANCERS FOR RECOMBINANT GENE EXPRESSION IN CHO CELLS
[patent_app_type] => utility
[patent_app_number] => 17/919890
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919890 | SUPER-ENCHANCERS FOR RECOMBINANT GENE EXPRESSION IN CHO CELLS | Apr 20, 2021 | Pending |
Array
(
[id] => 18675541
[patent_doc_number] => 20230313148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => iPSC INDUCTION
[patent_app_type] => utility
[patent_app_number] => 17/995969
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995969
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995969 | iPSC INDUCTION | Apr 15, 2021 | Pending |
Array
(
[id] => 18344696
[patent_doc_number] => 20230132806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => Systems and Methods for Control of Refractive Index and Optical Properties in Living Biological Cells
[patent_app_type] => utility
[patent_app_number] => 17/918108
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918108 | Systems and Methods for Control of Refractive Index and Optical Properties in Living Biological Cells | Apr 11, 2021 | Pending |
Array
(
[id] => 18389858
[patent_doc_number] => 20230158076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => AGENT FOR INCREASING CD25-POSITIVE REGULATORY T CELLS IN KIDNEYS
[patent_app_type] => utility
[patent_app_number] => 17/918390
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918390 | AGENT FOR INCREASING CD25-POSITIVE REGULATORY T CELLS IN KIDNEYS | Apr 8, 2021 | Pending |
Array
(
[id] => 18391674
[patent_doc_number] => 20230159892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => ENGINEERED IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/916974
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916974 | ENGINEERED IMMUNE CELLS | Apr 5, 2021 | Abandoned |
Array
(
[id] => 19921099
[patent_doc_number] => 12295354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
[patent_app_type] => utility
[patent_app_number] => 17/203398
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 16
[patent_no_of_words] => 53641
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203398
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203398 | Non-human animals expressing exogenous terminal deoxynucleotidyltransferase | Mar 15, 2021 | Issued |
Array
(
[id] => 18309341
[patent_doc_number] => 20230113241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => AUTOMATED METHOD FOR PREPARING KERATINOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/909354
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909354 | Automated method for preparing keratinocytes | Mar 1, 2021 | Issued |
Array
(
[id] => 20506042
[patent_doc_number] => 12540311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-03
[patent_title] => Crispr-based FOXP3 gene engineered t cells and hematopoietic stem cell precursors to treat IPEX syndrome patients
[patent_app_type] => utility
[patent_app_number] => 17/760264
[patent_app_country] => US
[patent_app_date] => 2021-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 13
[patent_no_of_words] => 17673
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760264
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760264 | Crispr-based FOXP3 gene engineered t cells and hematopoietic stem cell precursors to treat IPEX syndrome patients | Feb 12, 2021 | Issued |
Array
(
[id] => 18295386
[patent_doc_number] => 20230105072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => SYSTEM FOR STORING AND TRANSPORTING CELL LINES
[patent_app_type] => utility
[patent_app_number] => 17/799847
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799847 | SYSTEM FOR STORING AND TRANSPORTING CELL LINES | Feb 11, 2021 | Pending |
Array
(
[id] => 18972274
[patent_doc_number] => 20240052366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => Production of Lentiviral Vectors
[patent_app_type] => utility
[patent_app_number] => 17/799679
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799679 | Production of Lentiviral Vectors | Feb 3, 2021 | Pending |